Xpreza 200mg Tablet – Uses, Price & Azacitidine for Blood Cancer Treatment

Xpreza 200mg Tablet contains Azacitidine, is a chemotherapy agent commonly used for treating certain blood disorders, particularly myelodysplastic syndromes (MDS) and some cases of acute myeloid leukemia (AML).

Brand Name: Xpreza

Composition: Azacitidine

Mechanism of Action:

Azacitidine inhibits DNA methyltransferase enzymes by acting as a hypomethylating agent. This results in DNA hypomethylation, which can normalize cell proliferation or cell death by reactivating tumor suppressor genes that are typically repressed in cancer cells. Additionally, it combines with RNA to prevent the creation of proteins in cells that divide quickly.

Uses of Xpreza 200mg Tablet:

·       Myelodysplastic Syndromes

·       Acute Myeloid Leukemia

Dosage and Administration:

The tablet is taken orally. Always take Xpreza 200mg under a doctor's supervision. The dosage will be determined by your doctor based on your height, weight, and overall health.

Side Effects:

·       Fatigue

·       Weakness

·       Nausea

·       Vomiting

·       Loss of appetite

·       Diarrhea

·       Constipation

·       Anemia

·       Neutropenia

·       Thrombocytopenia

·       Injection site reactions (redness, pain, or swelling)

Safety Advise:

Liver  

Use with caution in patients with hepatic impairment, dose adjustments may be required. Kindly speak with your healthcare provider.

Kidney  

Use with caution in patients with renal impairment, dose adjustments may be required. Kindly speak with your healthcare provider.

Pregnancy  

Xpreza causes a risk to the fetus and should not be used during pregnancy. Kindly speak with your healthcare provider.

Breast Feeding  

Xpreza should not be taken when nursing because it tends to affect the infant through the breast milk. Kindly speak with your healthcare provider.

Alcohol  

Alcohol use should be avoided when using Xpreza since it may make you dizzy. Kindly speak with your healthcare provider.

Storage:

Store below 25°C, away from light.

How to use this Medication:

A medical practitioner administers azacitidine by subcutaneous or intravenous injection, usually once daily for seven days, with cycles repeated every four weeks as advised. Typically, treatment lasts for a minimum of four cycles.

After two cycles, if your condition has not improved and you have not encountered any severe adverse effects from the medicine, your doctor may decide to increase your dosage of azacitidine. If you have certain adverse effects, your doctor could also need to lower your dosage or postpone your treatment. Throughout your azacitadine treatment, be sure to update your doctor about your feelings.

 

Prior to each dose of azacitadine, your doctor will prescribe medication to prevent nausea and vomiting.

Disclaimer:

The main goal of Apothecare Specialities Pvt Ltd is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Specialities Pvt Ltd, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details:

Name: Natco Pharma Ltd
Address: Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India
Country of origin: India

Frequently Asked Questions (FAQs):

1. What is Xpreza 200mg Tablet used for?

Xpreza is used to treat myelodysplastic syndromes (MDS) and selected adults with acute myeloid leukaemia (AML).

2. How does Xpreza work?

It contains Azacitidine, which helps restore normal bone marrow function by reducing abnormal DNA methylation.

3. How should Xpreza 200mg Tablet be taken?

Take it exactly as prescribed, at the same time each day, with or without food.

4. Does Xpreza require regular blood tests?

Yes. Regular blood tests are required to monitor blood counts and assess treatment safety.

5. Is Xpreza a chemotherapy medicine?

Yes. Xpreza is an oral chemotherapy medicine belonging to the hypomethylating (demethylating) agent class.